The occurrence of hypertensive disorders of pregnancy (HDP) is associated with prematurity, intrauterine growth restriction, maternal and fetal perinatal mortality, and future cardiovascular disease in women. [1] [2] [3] Blood pressure (BP) levels are negatively associated with growth and gestational age at delivery, even in women who do not reach the HDP threshold. 4 The etiology of HDP is not fully understood but seems to involve lifestyle, environmental, and genetic features. 5 Factors such as maternal age over 40 years, nulliparity, prepregnancy overweight or obesity and low socioeconomic status have already been described to increase the risk of preeclampsia and are associated with BP variation, even in normotensive pregnant women. [6] [7] [8] Over the past decade, common genetic variants, such as single nucleotide polymorphism (SNP), arose as possible genetic risk factors associated with HDP. 9 Leptin is recognized to act in different sites of the human body and to have diverse metabolic functions. 10 
is produced mainly by adipocytes and, during pregnancy, by the placenta, which contributes to the increased concentrations during the gestational period. 10 Some studies have reported higher concentrations of leptin in women with HDP compared with normotensive women 11, 12 as well as a direct association between leptin and BP during healthy pregnancies. 8 Following this reasoning, common genetic SNPs of leptin and leptin receptor genes, such as leptin G2548A and leptin receptor Q223R and K109R, associated with leptin gene expression and function seem to have the potential to influence BP during pregnancy. 13 These polymorphisms are associated with hypertension and obesity in the adult population. 14, 15 However, only a few studies have evaluated the association between these polymorphisms with HDP, and they presented controversial results. [16] [17] [18] [19] Furthermore, to the best of our knowledge, no study has evaluated the association of common leptin and leptin receptor gene SNPs with BP trajectories during normal pregnancy.
Considering the fact that the genetic component related to HDP occurrence is still not elucidated, investigations on the association between common genetic polymorphisms and BP trajectories during pregnancy appear promising and are required. Thus, the aim of this study was to evaluate the associations between polymorphisms of leptin (G2548A) and leptin receptor (Q223R and K109R) genes and BP changes during pregnancy and the postpartum period in normotensive women and to assess whether leptin and leptin receptor genotypes modify the well-known effect of body mass index (BMI) on BP.
METHODS
The study was approved by the Research Ethics Committees of the Municipal Secretariat of Health of the State of Rio de Janeiro. The design comprised a prospective cohort that followed women during pregnancy and postpartum at a Public Health Center in Rio de Janeiro, Brazil. Women were evaluated during 4 follow-up periods: between 5-13 (baseline), 20-26 and 30-36 gestational weeks, and 30-45 days postpartum. Ninety-two percent of the invited women agreed to participate in the study (n = 299) and after cohort exclusions (confirmed pregestational diagnosis of chronic noncommunicable diseases (except obesity) (n = 12), diagnosis of infectious or parasitic diseases (n = 9), twin pregnancies (n = 4), missed baseline evaluation (n = 20), or miscarriage (n = 25)) the cohort sample comprised 229 apparently healthy pregnant women. We further excluded women with hypertension during pregnancy (n = 2) and those who suffered stillbirth (n = 5). We were not able to obtain blood samples (n = 66) or detect leptin or leptin receptor genes polymorphisms (n = 10) of 76 women. Thus, our baseline sample was composed of 146 pregnant women.
Systolic (SBP) and diastolic BP (DBP) were measured using an automated oscillometric BP monitoring system (Omron HEM-742, São Paulo, Brazil). 20 BP was measured twice at each follow-up visit with an approximately 30-minute interval between measurements, and the mean values were used. 21 Fasting (12 hours) blood samples were collected at each follow-up visit by a trained professional. Serum and plasma were separated (centrifuged at 5,000 rpm for 5 minutes) and aliquoted, and a blood sample was collected into vacutainer tubes containing EDTA, which were then stored at −80 °C until the analyses. DNA was extracted by the phenol-chloroform method. 22 Leptin gene (rs7799039; G2548A) and leptin receptor gene (rs1137101; Q223R and rs1137100; K109R) genotypes were determined by real-time PCR amplification (StepOnePlus, Life Technologies) using an allelic discrimination assay (TaqMan Genotyping Master Mix assay, Life Technologies). Plasma leptin (ng/ml; sensitivity of 0.5 ng/ml) and insulin (µU/ml; sensitivity of 2 µU/ml) were measured by the enzyme-linked immunosorbent assay (Millipore kit, St. Charles, MO). Serum glucose was measured using an enzymatic colorimetric method with a Wiener Lab kit (Rosario, Argentina). Insulin resistance (IR) was estimated by the Homeostasis Model of Assessment. 23 Women's height was measured in duplicate with a portable stadiometer (Seca, Ltd, Hamburg, Germany) at baseline, and the mean value was used. Body weight was measured using a digital scale (Filizola, Ltd, São Paulo, Brazil) and BMI was calculated at all follow-up visits. The anthropometric measurements were performed by standardized and trained interviewers. 24 Gestational age was estimated using data from the first ultrasonography examination (n = 143) or the reported date of the last menstrual (n = 3). The following socioeconomic, demographic, reproductive, and lifestyle variables were obtained using structured questionnaires at the baseline visit: maternal age (years), self-reported skin color (White/ mixed or Black), education (years of schooling), parity (nulliparous/≥1 parturition), smoking habit (no/yes), alcohol consumption (no/yes), and prepregnancy participation in leisure-time physical activity (no/yes).
Statistical analysis
The sample characteristics were described by means and SD, medians and interquartile ranges, or absolute and relative frequencies (%). Genotype frequencies were calculated and Hardy-Weinberg equilibrium determined. The haplotype frequencies were estimated using the expectationmaximization algorithm. The polymorphisms were the main independent variables and were evaluated using either dominant or recessive models. We used the recessive model for G2548A (AG/GG vs. AA) and Q223R (AA/AG vs. GG) polymorphisms. For the G2548A, the option was based on the genotype association with BP in our sample, while for Q223R polymorphism it was based on the available literature. 16, 25 The dominant model (AG/GG vs. AA) was used for the leptin receptor K109R polymorphism and it was based on the available literature. 16, 25, 26 Comparisons across genotypes categories for maternal characteristics were performed using the chi-square test for categorical variables and Student's t test for continuous variables. Leptin concentration was an exception and was compared using the MannWhitney U test due to its skewed distribution. 27 Crude and adjusted linear regression models were conducted to evaluate the association of polymorphisms with SBP, DBP, and leptin concentrations at each study visit. We further used longitudinal linear mixed-effect models to investigate whether the polymorphisms are associated with BP trajectories during pregnancy and the postpartum period and to assess whether there was an interaction between maternal BMI and the genetic polymorphisms. 28, 29 Time elapsed after conception (weeks) was fitted as random effect and using an unstructured covariance matrix, in order to accommodate for the wide variability in slopes over time among subjects. All other covariates were analyzed as fixed effects only. We further included the quadratic time variable to fit for the nonlinear variation in BP during pregnancy.
The variables included in the adjusted models were chosen based on the biological plausibility of the associations with both polymorphisms and BP. The SBP and DBP models were adjusted for the women's age (years), education (years of schooling), skin color (White/mixed or Black), family history of hypertension (none or 2 nd degree/1 st degree), parity (0/≥ 1 parturitions), BMI (time-dependent, kg/m 2 ), prepregnancy leisure-time physical activity (no/yes), early pregnancy smoking habit (no/yes), and homeostasis model of assessment-insulin resistance (1 st and 2 nd /3 rd tertile of the sample distribution). Furthermore, interaction terms between BMI (time-dependent) and gene polymorphisms were included to examine for the potential effect modification of SNPs over the associations between BMI and BP levels. The models having log leptin as the outcome were adjusted for age, education, skin color, parity, BMI, prepregnancy leisure-time physical activity, and early pregnancy smoking habit. Three types of diagnostic plots were produced to evaluate the quality of the multiple models: scatter and quantile-quantile plots of residuals and plots to check the possible autocorrelation structure.
Effect plots containing data scatter, longitudinal prediction, and 95% confidence intervals (CIs) were constructed to illustrate the variation in BP during pregnancy and the postpartum period according to leptin gene polymorphism genotypes and to graphically represent the interaction between polymorphism and BMI.
Statistical analyses were performed using Stata Data Analysis and Statistical Software (STATA) version 12.0 (Stata Corp, College Station, TX) and graphs were performed using R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2015).
RESULTS
We evaluated 146 women in the first, 136 in the second, and 141 in the third pregnancy trimester and 133 at the postpartum visit (8.9% loss to follow-up). The genotypes (AA, AG, and GG) and the allele frequencies (A or G) of the 3 SNPs (G2548A, Q223R, and K109R) were in HardyWeinberg equilibrium (Supplemental Table 1 ).
The most frequent haplotype (of leptin receptor Q223A and K109R polymorphisms) was A-A (47.1%), followed by A-G (30.2%), and G-G (22.7%). After estimating haplotype frequencies, no women were classified as having a G-A haplotype (data not shown). We compared baseline characteristics of women with (n = 146) and without (n = 76) genetic information and only observed that the sample evaluated in this study presented a lower frequency of prepregnancy leisure-time physical activity compared with those without genetic information (Supplemental Table 2 ).
Women who presented the AA genotype of G2548A polymorphism presented higher education level and lower early pregnancy BMI than those with the G-allele. Women presenting the AA genotype of K109R polymorphism were younger and had lower early pregnancy BMI and homeostasis model of assessment-insulin resistance compared with women presenting G-allele (Table 1) .
In the adjusted linear regression models, we observed that the G-allele of leptin gene G2548A polymorphism was positively associated with SBP at the first trimester. We observed the same trend for DBP, but the association was statistically borderline. No significant association was found between K109R and Q223R polymorphisms and BP levels and logleptin concentrations during pregnancy and postpartum period ( Table 2) .
We found in the adjusted linear mixed-effect models that women carrying the G-allele of G2548A polymorphism began pregnancy with higher SBP and DBP levels compared with the AA genotype, and the levels remained higher throughout pregnancy and the postpartum period, but the pattern of BP change were similar between groups ( Figure 1) . Women who had the G-allele of the leptin receptor's K109R polymorphism presented the same trend, but the association was no longer statistically significant after adjustments. We did not observe significant associations between Q223R polymorphism and BP changes. There was an interaction between pregnancy BMI and the leptin gene genotypes (G2548A), in which the effect of BMI on increasing BP was steeper in women homozygous for the A-allele, compared with those with AG/GG genotypes. This interaction was statistically significant only for SBP, but in the model for DBP, we observed the same trend (Tables 3 and 4 and Figure 2 ).
Women classified as having the G-G haplotype of the leptin receptor gene polymorphisms (Q223R and K109R) were associated with a higher SBP (β =2.7; 95% CI = 0.1-5.3; P = 0.038) and DBP (β = 3.4; 95% CI = 1.3-5.6; P = 0.002) in the first pregnancy trimester compared with those with the A-A haplotype, but these associations were no longer significant after adjustments (β SBP = 1.6; 95% CI = −08 to 4.1; P = 0.181; β DBP = 1.9; 95% CI = −0.1 to 3.9; P = 0.064). We did not find significant associations between the haplotypes and the SBP and DBP in the adjusted longitudinal models (data not shown).
DISCUSSION
This study has 2 main findings. First, we found that leptin gene polymorphism (G2548A) is significantly associated with SBP and DBP variation during pregnancy and postpartum period. Women carrying the G-allele presented higher BP levels during pregnancy compared with those with AA genotype. Second, we observed a significant interaction between G2548A polymorphism and BMI, in which the effect of BMI on BP variation was higher in the women homozygote for the A-allele compared with those with at least one G-allele. We did not observe significant associations between polymorphisms of the leptin receptor gene (Q223R and K109R) and BP variation. Table 2 . Linear regression models between leptin gene and leptin receptor gene polymorphisms genotypes and blood pressure and leptin concentration throughout pregnancy and early postpartum of women followed at a public health center in Rio de Janeiro, Brazil The models for SBP and DBP were adjusted for age, education, skin color, family history of hypertension, parity, BMI, pre-pregnancy leisure-time physical activity and early pregnancy smoking habit and HOMA-IR; the models for leptin were adjusted for age, education, skin color, parity, BMI, prepregnancy leisure-time physical activity, and early pregnancy smoking habit.
The relatively small sample size represents the main limitation of the study. We had 222 eligible women, but managed to collect blood samples and genotyped polymorphisms in only 146 women (65.8%). Despite the missing data, we did not observe significant differences in baseline BP levels, leptin concentrations and socioeconomic, demographic, and anthropometric characteristics between the 146 women included in the study and the 76 without polymorphism information. In particular, the subgroup with the AA genotype of the leptin gene G2548A polymorphism was very small, and the findings in this subgroup should be considered hypothesis generating, which should be confirmed in larger cohorts of pregnant women. By contrast, the longitudinal design enable us to use a statistical procedure (linear mixed-effect models) that allows the evaluation of individuals with missing information, which is the main strength of the study. Moreover, as far as we know, this is the first study to evaluate the longitudinal variation of BP during pregnancy according to leptin and leptin receptor gene polymorphisms in normotensive pregnancies.
The leptin gene G2548A polymorphism occurs at the gene promoter and consists of a substitution of glutamine to adenine at nucleotide 2548 in the 5' region. 30, 31 It was suggested that this polymorphism is associated with gene expression and leptin secretion and may explain the existence of individual variations in leptin concentrations independent of body fat. 13 Few studies have evaluated the effect of leptin gene polymorphism (G2548A) on the occurrence of HDP. Sugathadasa et al. 19 evaluated 62 women with preeclampsia/ HDP and 63 ethnicity-and gestation-age-matched controls and found that women with at least one A-allele presented an increased relative risk of presenting preeclampsia/HDP compared with those having the GG genotype (Relative risk = 1.67; 95% CI = 1.28-2.18; P < 0.001). Although we found that the G-allele was associated with increased BP levels throughout pregnancy and postpartum, we also observed that BMI appeared to have a different effect on BP depending on the leptin polymorphism genotypes. In our sample, women who had the AA genotype presented a steeper correlation between BMI and BP variation than did the G-allele carriers. We have observed that women with the AA genotype had lower BMIs compared with those carrying the G-allele, whereas in the study conducted by Sugathadasa et al., 19 the opposite was observed. The interaction between pregnancy BMI and leptin SNP and the differences observed in the body composition might explain the divergent results between the Sugathadasa et al. study 19 and ours. Leptin has already been described as associated with hypertension during pregnancy, 11, 12 and because leptin acts through its receptor, 32 we hypothesized that leptin receptor gene polymorphisms would influence leptin function and thereby affect BP. Both leptin receptor polymorphisms evaluated in this study are nonsynonymous. The Q223R polymorphism involves the change of an adenine to a guanine in exon 6 at nucleotide 668 of codon 223, resulting in replacement of the amino acid glutamine by arginine in the protein. The K109R polymorphism occurs by the change of an adenine to a guanine in codon 109 at position 326 in exon 4, also causing an amino acid change (lysine to arginine) in the resultant protein. In our sample, the leptin receptor polymorphism (K109R) was associated with higher DBP levels in the first trimester, but the association lost significance after adjustments for BMI and homeostasis model of assessment-insulin resistance in the longitudinal models. Similarly, studies Model 1 was adjusted only for gestational age and quadratic gestational age. Model 2 was further adjusted for age, education, skin color, family history of hypertension, parity, BMI, prepregnancy leisure-time physical activity, first trimester smoking habit, and HOMA-IR; G2548A model 2 was additionally adjusted for the interaction between G2548A and BMI. Abbreviations: BMI, body mass index; CI, confidence interval; HOMA-IR. homeostatic model assessment-insulin resistance.
a β, linear mixed-effect regression coefficient. b P value refers to the maximum likelihood estimator.
investigating the association between the leptin receptor and HDP did not find statistically significant results. 16, 25 We did not observe any significant association of leptin receptor gene polymorphism Q223R either with SBP or with DBP variation during pregnancy. In the same line of genotype results, when we analyzed the association of haplotypes and BP changes throughout pregnancy, we found no significant association after adjusting for confounders in both cross-sectional and longitudinal models. In the literature, studies of this association are still inconclusive. The G-allele of leptin receptor gene polymorphism Q223R was previously reported to be associated with severe preeclampsia 16 and with increased DBP only in the postpartum period for women who have had HDP. 18 By contrast, Tennekoon et al. 33 evaluated 61 women with HDP and 40 normotensive controls and did not find any differences in Q223R polymorphism between the groups. Fong et al. 26 conducted a meta-analysis to evaluate the association between maternal genotypes (including K109R and Q223R) and severe preeclampsia. The authors found a positive association only with the K109R genotype. The 2 studies regarding K109R polymorphisms did not show statistically significant results when they were analyzed separately, probably due to the modest sample size. 16, 25 Little is known about the effect of leptin receptor polymorphisms in BP changes during pregnancy because most of the studies in the literature evaluated women with preeclampsia and did not report BP measures. This fact makes comparisons with our results difficult. We did not find any significant associations between the polymorphisms and log leptin throughout pregnancy and the postpartum period in both crude and adjusted analyses. Although previous studies with nonpregnant individuals reported a significant association between G2548A, Q223R, and K109R and leptin concentrations 13, 34, 35 in a study with 322 Thai volunteers, the authors failed to find significant associations. 36 Few studies evaluated this relation during pregnancy and, in line with our results, did not find statistically significant associations. 19, 33 We hypothesize that during pregnancy, the placental expression of leptin, which seems to be regulated by key pregnancy molecules, 37 may regulate plasma concentrations to maintain gestational requirements; thus, maternal leptin concentrations are not significantly affected by leptin or leptin receptor polymorphisms.
In conclusion, this study revealed new evidence regarding the effect of common genetic variants of leptin and leptin receptors on BP trajectories in Brazilian normotensive pregnant women. We found that the leptin gene polymorphism (G2548A) is significantly associated with the SBP and DBP levels during pregnancy and the postpartum period. Furthermore, the effect of BMI on BP apparently differed according to the women's genotype, in which women homozygous for the A-allele presented a higher effect of BMI on BP levels than women with at least one G-allele, suggesting that interactions between genetic and environmental factors are important for BP variation throughout pregnancy. This is an initial step to a better understanding of how genetic factors can influence BP trajectories during pregnancy; therefore, future studies with larger sample sizes and different ethnic populations are required.
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